Concourse Financial Group Securities, Inc. Biogen Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 7 shares of BIIB stock, worth $1,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 22 68.18%
Holding current value
$1,043
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
SELL
$189.07 - $236.8 $2,836 - $3,552
-15 Reduced 68.18%
7 $1,000
Q2 2024

Jul 23, 2024
SELL
$190.52 - $236.72 $571 - $710
-3 Reduced 12.0%
22 $5,000
Q1 2024

Apr 30, 2024
SELL
$212.02 - $267.71 $8,692 - $10,976
-41 Reduced 62.12%
25 $5,000
Q4 2023

Feb 07, 2024
SELL
$222.59 - $267.94 $1,335 - $1,607
-6 Reduced 8.33%
66 $17,000
Q3 2023

Oct 25, 2023
BUY
$253.3 - $285.89 $10,638 - $12,007
42 Added 140.0%
72 $18,000
Q2 2023

Aug 10, 2023
BUY
$275.25 - $318.06 $825 - $954
3 Added 11.11%
30 $8,000
Q1 2023

May 15, 2023
BUY
$256.56 - $292.34 $1,282 - $1,461
5 Added 22.73%
27 $7,000
Q4 2022

Jan 30, 2023
BUY
$252.44 - $306.72 $1,767 - $2,147
7 Added 46.67%
22 $0
Q1 2022

May 09, 2022
SELL
$193.77 - $244.14 $11,044 - $13,915
-57 Reduced 79.17%
15 $3,000
Q4 2021

Feb 07, 2022
SELL
$223.92 - $287.77 $22,392 - $28,777
-100 Reduced 58.14%
72 $17,000
Q3 2021

Nov 09, 2021
BUY
$282.99 - $369.05 $28,299 - $36,905
100 Added 138.89%
172 $49,000
Q2 2021

Aug 13, 2021
SELL
$259.0 - $414.71 $32,116 - $51,424
-124 Reduced 63.27%
72 $24,000
Q1 2021

May 13, 2021
BUY
$242.95 - $284.63 $12,390 - $14,516
51 Added 35.17%
196 $55,000
Q4 2020

Feb 02, 2021
SELL
$236.26 - $355.63 $472 - $711
-2 Reduced 1.36%
145 $36,000
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $30,978 - $35,768
-117 Reduced 44.32%
147 $42,000
Q2 2020

Aug 13, 2020
SELL
$258.66 - $342.55 $5,431 - $7,193
-21 Reduced 7.37%
264 $71,000
Q1 2020

May 13, 2020
SELL
$268.85 - $341.04 $6,452 - $8,184
-24 Reduced 7.77%
285 $90,000
Q4 2019

Feb 14, 2020
BUY
$220.06 - $304.07 $25,967 - $35,880
118 Added 61.78%
309 $92,000
Q3 2019

Nov 13, 2019
SELL
$217.44 - $243.88 $71,972 - $80,724
-331 Reduced 63.41%
191 $44,000
Q2 2019

Aug 13, 2019
BUY
$219.29 - $241.72 $59,208 - $65,264
270 Added 107.14%
522 $122,000
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $23,621 - $36,946
109 Added 76.22%
252 $59,000
Q4 2018

Feb 14, 2019
BUY
$278.5 - $352.75 $12,532 - $15,873
45 Added 45.92%
143 $43,000
Q3 2018

Nov 13, 2018
BUY
$293.51 - $383.83 $28,763 - $37,615
98 New
98 $35,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email